Surgery News and Research

RSS

Private equity sees the billions in eye care as firms target high-profit procedures

Christina Green hoped cataract surgery would clear up her cloudy vision, which had worsened after she took a drug to fight her breast cancer.

19 Sep 2022

Engineers create a small, non-invasive device that measures changes in tumor size

Engineers at the Georgia Institute of Technology and Stanford University have created a small, autonomous device with a stretchable/flexible sensor that can be adhered to the skin to measure the changing size of tumors below.

16 Sep 2022

Study shows differences in treatment outcomes for Black vs. white women with hormone receptor-positive breast cancer

A study led by City of Hope, one of the largest cancer research and treatment organizations in the United States, found that Black women with Stage 1 or 2 breast cancer were almost three times more likely than white women to have tumor shrinkage from hormone therapy delivered prior to surgery, yet Black women were more likely than their white counterparts to have worse outcomes when this type of endocrine therapy before surgery was used at a later stage of disease.

16 Sep 2022

FAU researchers explore the impacts of COVID-19 pandemic on resident physicians

The COVID-19 pandemic has had many deleterious consequences for health care workers, including the challenges of caring for severely ill patients. Resident physicians, in particular, may have been affected by physical as well as psychological consequences of the pandemic. At present, data are sparse on the perceptions, coping strategies and mental health of residents during COVID-19.

16 Sep 2022

New abortion laws jeopardize cancer treatment for pregnant patients

As abortion bans go into effect across a contiguous swath of the South, cancer physicians are wrestling with how new state laws will influence their discussions with pregnant patients about what treatment options they can offer.

16 Sep 2022

Two novel tools may simplify, quicken and improve ear reconstruction surgery

According to the National Birth Defects Prevention Network, one in every 8,000 to 10,000 births in the United States result in one of two congenital malformations of the ear: microtia (the child is born with only a cartilage stump for an ear) or anotia (the complete lack of an ear).

15 Sep 2022

Father of modern corneal science honored with the 2022 António Champalimaud Vision Award

Claes H. Dohlman, MD, PhD, whose pioneering research at Mass Eye and Ear and in the Department of Ophthalmology at Harvard Medical School (HMS) has forever changed the way conditions of the cornea are understood and treated, has been presented with the 2022 António Champalimaud Vision Award for his vast contributions to vision research.

15 Sep 2022

Disruption of actin cytoskeleton is key to triggering human immune response, research finds

Researchers from Cleveland Clinic's Florida Research and Innovation Center (FRIC) found that disruption of a cellular structure, known as the actin cytoskeleton, is a "priming signal" for the body to respond to a virus.

15 Sep 2022

Winners of the 2022 CURE-19 Research Pilot Grants announced

The Arnhold Institute for Global Health at the Icahn School of Medicine at Mount Sinai and NYC Health + Hospitals have announced the 2022 awardees of the CURE-19 Research Pilot Grants, an initiative to support collaborative, interdisciplinary COVID-19 research that will address both the pandemic and root causes of health disparities in New York City.

14 Sep 2022

Microneedle technology for low-cost, painless, and bloodless tattoos

Instead of sitting in a tattoo chair for hours enduring painful punctures, imagine getting tattooed by a skin patch containing microscopic needles.

14 Sep 2022

Bariatric surgery associated with long-term improvements in pain, physical function, work productivity

Improvements in pain, physical function and work productivity largely endure for at least seven years after bariatric surgery, despite some backsliding from the high levels of improvement seen in the years immediately following surgery, University of Pittsburgh epidemiologists report today in JAMA Network Open.

14 Sep 2022

Signal transduction via the EGFR pathway likely to be involved in lenvatinib resistance

The multitargeted tyrosine kinase inhibitor (MKI), lenvatinib, is widely used to treat advanced and metastatic thyroid cancer. However, the molecular mechanisms by which thyroid cancer cells become resistant to lenvatinib remain poorly understood. In this study, we demonstrated, for the first time, that activation of the epidermal growth factor receptor (EGFR)-mediated signaling pathway is involved in lenvatinib resistance in thyroid cancer cells.

14 Sep 2022

Study highlights role of tumor-infiltrating B cells, plasma cells in cancer development and treatment outcomes

Through extensive single-cell analysis, researchers at The University of Texas MD Anderson Cancer Center have created a spatial map of tumor-infiltrating B cells and plasma cells in early-stage lung cancers, highlighting previously unappreciated roles these immune cells play in tumor development and treatment outcomes.

13 Sep 2022

Study explores olfactory dysfunction in long COVID patients

A new study described the sociodemographic features and comorbidities of patients with long COVID and olfactory dysfunction.

13 Sep 2022

Study identifies mechanism behind 'cytokine storm' in COVID-19 patient lungs

A new study by HSS Research Institute scientists identifies a mechanism by which SARS-CoV-2 induces the inflammatory response in COVID-19 patient lungs, so-called "cytokine storm", that can lead to lasting tissue damage and poor patient outcomes.

13 Sep 2022

Immunotherapy before surgery improves outcomes in many patients with stage II–IV cutaneous squamous cell carcinoma

In an international, multicenter Phase II clinical trial led by The University of Texas MD Anderson Cancer Center, 63.3% of patients with stage II–IV cutaneous squamous cell carcinoma (CSCC) saw their tumors nearly or completely disappear when treated with immunotherapy before surgery.

13 Sep 2022

Surgery News and Research

Private equity sees the billions in eye care as firms target high-profit procedures

Engineers create a small, non-invasive device that measures changes in tumor size

Study shows differences in treatment outcomes for Black vs. white women with hormone receptor-positive breast cancer

FAU researchers explore the impacts of COVID-19 pandemic on resident physicians

New abortion laws jeopardize cancer treatment for pregnant patients

Two novel tools may simplify, quicken and improve ear reconstruction surgery

Father of modern corneal science honored with the 2022 António Champalimaud Vision Award

Disruption of actin cytoskeleton is key to triggering human immune response, research finds

Winners of the 2022 CURE-19 Research Pilot Grants announced

Microneedle technology for low-cost, painless, and bloodless tattoos

Bariatric surgery associated with long-term improvements in pain, physical function, work productivity

Signal transduction via the EGFR pathway likely to be involved in lenvatinib resistance

Study highlights role of tumor-infiltrating B cells, plasma cells in cancer development and treatment outcomes

Study explores olfactory dysfunction in long COVID patients

Study identifies mechanism behind 'cytokine storm' in COVID-19 patient lungs

Immunotherapy before surgery improves outcomes in many patients with stage II–IV cutaneous squamous cell carcinoma

Medical coding creates barriers to care for transgender patients

MSK researchers reveal a promising treatment option for bladder cancer patients

New long-term opioid use associated with a heightened risk of death, study finds

Saline nasal irrigation after COVID-19 diagnosis reduces hospitalization

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News